Varian Medical Systems, Inc. (VAR) News

Varian Medical Systems, Inc. (VAR): $177.07

-0.04 (-0.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter VAR News Items

VAR News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

VAR News Highlights

  • For VAR, its 30 day story count is now at 10.
  • Over the past 21 days, the trend for VAR's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about VAR are PTC, DOW and STEP.

Latest VAR News From Around the Web

Below are the latest news stories about Varian Medical Systems Inc that investors may wish to consider to help them evaluate VAR as an investment opportunity.

Lattice Semi, Progyny, Domtar shoot higher on S&P index moves

Stocks are on the move after hours following the most recent changes from S&P Dow Jones Indices, starting with PTC. Currently a constituent of the S&P MidCap 400, PTC will move into the S&P 500 to replace Varian Medical Systems (VAR), which was acquired today by Siemens Healthineers. Moving into...

Seeking Alpha | April 15, 2021

PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600

S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, April 20:

Yahoo | April 15, 2021

Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive Year

Varian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the fourth year in a row. Varian's Net Promoter Score improved by 7.3 percentage points from 2019 to 2020.

Yahoo | April 12, 2021

Varian (VAR) Inks Deal With Google Cloud to Boost Cancer Care

Varian (VAR) partners with Google Cloud to help in the fight against cancer through the development of an advanced AI based diagnostic platform.

Yahoo | April 12, 2021

Varian and Google Cloud Collaborate to Aid in the Fight Against Cancer

Varian (NYSE: VAR) today announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation—a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow.

Yahoo | April 8, 2021

Siemens Healthineers Offers More Than Just Acquired Growth And Synergy Opportunities

The market’s mood has certainly improved where Siemens Healthineers (SMMNY) (SEMHF) is concerned. Whether that’s due to a strong fiscal first quarter result that showed a good recovery in imaging, the fact that the Varian (VAR) financing is complete and on better-than-expected terms, or just improving sentiment, I don’t think...

Stephen Simpson on Seeking Alpha | April 7, 2021

Varian Medical (VAR) Hits 52-Week High: What's Driving It?

Varian Medical (VAR) is optimistic about its prospective acquisitions and strength in Proton Therapy segment.

Yahoo | March 26, 2021

Varian Medical Systems Invests in Bend It Technologies, Ltd., a Company Developing Novel Steerable Microcatheters

Varian (NYSE: VAR) today announced a new investment in Bend It Technologies Ltd., a medical device company based in Petach Tikva, Israel, that is developing the Bendit® steerable microcatheters for use by interventionalists performing minimally-invasive peripheral vascular procedures. They can be used to deliver diagnostic, embolic, or therapeutical materials into the vasculature.

Yahoo | March 25, 2021

Why You Should Retain Varian (VAR) in Your Portfolio Now

Investor optimism is high on the Varian (VAR) stock, courtesy of its solid prospects.

Yahoo | March 25, 2021

The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Veric...

Benzinga | March 19, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0108 seconds.